Rheumatology is a holistic super speciality of Internal Medicine that deals with arthritis and rheumatism.
Rheumatic conditions comprise over 150 diseases and syndromes, which are usually progressive and associated with pain.1
Arthritis is the major Rheumatology disorder and affects 15% people i.e. over 180 million people in India. This prevalence is higher than many well known diseases such as diabetes, AIDS and cancer.1
Major rheumatic disorders treated by rheumatologists.2 3 4
Spondyloarthopathies (Ankylosing, Psoriatic and etc..)
Juvenile Idiopathic Arthritis
Crystal Arthropathies (Gout)
Systemic conditions and connective tissue diseases
Biologics and Biosimilars play an important role in the rheumatology segment. The overall biologics market in India is estimated to be $30 million in 2016, growing at a CAGR of 24% from 2014-16 and is one of the fastest emerging therapy areas in the rheumatology segment5. Biosimilars will increase the access to and expand the use of biologics, which may lead to better overall health outcomes as well as savings and efficiencies to the health care system.